Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Phosphoproteomics and global proteomic analysis of gastric cancer cell lines

ABSTRACT: proteome, pSTY proteome and pY proteome analysis was performed using 13 gastric cancer cell lines w/wo apatinib treatment.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Jun Adachi

PROVIDER: PXD037961 | JPOST Repository | Sat Nov 04 00:00:00 GMT 2023

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	180809_T1_GC_control_fr1.raw	Raw
	180809_T1_GC_control_fr2.raw	Raw
	180809_T1_GC_control_fr3.raw	Raw
	180809_T1_GC_control_fr4.raw	Raw
	180809_T1_GC_control_fr5.raw	Raw

Items per page:

1 - 5 of 20

Publications

Integration of pharmacoproteomic and computational approaches reveals the cellular signal transduction pathways affected by apatinib in gastric cancer cell lines.

Nojima Yosui Y Aoki Masahiko M Re Suyong S Hirano Hidekazu H Abe Yuichi Y Narumi Ryohei R Muraoka Satoshi S Shoji Hirokazu H Honda Kazufumi K Tomonaga Takeshi T Mizuguchi Kenji K Boku Narikazu N Adachi Jun J

Computational and structural biotechnology journal 20230315

Apatinib is known to be a highly selective vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with anti-angiogenic and anti-tumor properties. In a phase III study, the objective response rate to apatinib was low. It remains unclear why the effectivity of apatinib varies among patients and what type of patients are candidates for the treatment. In this study, we investigated the anti-tumor efficacy of apatinib against 13 gastric cancer cell lines and found that it differed depending ...[more]

PMID: 37013003

Similar Datasets

Gastric Cancer Cell Lines

Project description:Regions of recurrent genomic amplification and deletion are frequently observed in primary gastric cancers (GC). However, identifying specific oncogenes and tumor suppressor genes within these regions can be challenging, as they often cover tens to hundreds of genes. Here, we combined high-resolution array-based comparative genomic hybridization (aCGH) with gene expression profiling to target genes lying within focal high-level amplifications in GC cell lines, and identified RAB23 as an amplified and overexpressed Chr 6p11p12 gene in Hs746T cells. High RAB23 protein expression was also observed in some lines lacking RAB23 amplification, suggesting additional mechanisms besides gene amplification for up-regulating RAB23. siRNA silencing of RAB23 reduced the invasive potential of both amplified and nonamplified GC cell lines. RAB23 gene amplifications were observed in 13% of primary gastric carcinomas. In two independent patient cohorts, RAB23 transcript and protein expression was significantly associated with diffuse-type gastric cancer (dGC) compared to intestinal-type gastric cancer (iGC), providing further evidence that dGC and iGC likely represent two molecularly distinct tumor types. Our study demonstrates that investigating focal chromosomal amplifications by combining highresolution aCGH with expression profiling is a powerful general strategy for identifying novel cancer genes in recurrent regions of chromosomal aberration. Keywords: gastric cancer cell lines, comparative genomic hybridization, gene expression profiling

2008-12-29 | GSE10611 | GEO

Gastric Cancer Cell Lines

2010-05-14 | E-GEOD-10611 | biostudies-arrayexpress

LC-MSMS based (phospho)proteomics on gastric cancer cell lines

Project description:We exploit a large panel of gastric cancer cell lines and three powerful (phospho)proteomic workflows, including tyrosine phosphorylation profiling, to provide the characterization of the gastric cancer proteome. The resulting datasets are used individually and in an integrated manner to generate novel subclassifications with subtype-specific molecular features.

2024-12-16 | PXD048538 | Pride

Proteome and Phosphoproteome of colorectal cancer cancer cells

Project description:Total, pSTY, and pY proteome of colorectal cancer cells labeled by TMTpro reagent.

2024-02-27 | PXD040404 | JPOST Repository

PGRC Cancer Proteome Study of Gastric Tissue

Project description:The goal of the project is to analyze different layers of proteome information including protein abundance and post-translational modifications of PGRC gastric tissue samples. Three pairs of human gastric cancer and adjacent normal tissues were extensively characterized by serial enrichments of phosphorylation and N-glycosylation (SEPG) coupled to LC-MS/MS method.

2017-03-31 | MSV000080818 | MassIVE

DNA methylation analysis in normal gastric epithelial cells and gastric cancer cell lines

Project description:Genome wide DNA methylation profiling of normal gastric epuithelial cells and gastric cancer cell lines. The Illumina Infinium 450k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 450,000 CpGs. Samples included 2 normal gastric epithelial cells and 14 gastric cancer cells.

2020-08-31 | GSE136244 | GEO

Gastric cancer ascites proteome

Project description:Gastric cancer is one of the most lethal malignancies with high mortality and gastric cancer-specific biomarker is need due to the lack of specific method for early screening, diagnosis, and prognosis of the patients with gastric cancer. Ascites is known for an important source for conducing biomarker discovery because it contains the secreted proteins from malignant cells, growth factors, and cytokines. In this study, we have conducted a comprehensive proteome study using ascites of patients with inflammatory diseases and gastric cancer. In the discovery stage, we have identified 2761 ascites-specific proteins, where 234 proteins were quantitated using the label free quantitation method, the normalized spectral abundance factor (NSAF); 152 and 82 proteins showed up and down-regulated pattern, respectively. Our ascites proteome can be used as baseline data for the discovery of novel biomarkers of the gastric cancer.

2018-04-16 | PXD002213 | Pride

Epigenetic analysis of gastric cancer cell lines

2012-05-03 | GSE29499 | GEO

Copy number profiling of gastric cancer cell lines and gastric tumor tissues

Project description:Copy number profiling of 27 gastric cancer cell lines and 105 gastric tumor tissues. we hypothesized that a detailed fine-scale survey of genomic CNAs might reveal potential genes disrupted by fusion events in gastric cancer. We inferred the locations of likely chromosomal breakpoints by identifying regions where closely-spaced microarray probes exhibited striking transitions in copy number. 27 gastric cancer cell lines and 105 gastric tumor tissues were profiled by Agilent 244K microarray.

2010-12-31 | E-GEOD-22694 | biostudies-arrayexpress

Epigenetic analysis of gastric cancer cell lines

Project description:Genome wide DNA methylation profiling of gastric cancer cell lines. The Illumina Goldengate DNA methylation Beadchip was used to obtain DNA methylation profiles across 1,505 CpG CpGs in 20 gastric cancer cell lines. Bisulphite converted DNA from the 20 gastric cancer cell lines were hybridised to the Illumina Goldengate Methylation Beadchip

2012-05-02 | E-GEOD-29499 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data